Gravar-mail: Comparison of (123)I-Metaiodobenzylguanidine (MIBG) and (131)I-MIBG Semi-Quantitative Scores in Predicting Survival in Patients With Stage 4 Neuroblastoma: A Report From the Children’s Oncology Group